These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 24770808)

  • 21. Intravesical prostatic protrusion is better than prostate volume in predicting the outcome of trial without catheter in white men presenting with acute urinary retention: a prospective clinical study.
    Mariappan P; Brown DJ; McNeill AS
    J Urol; 2007 Aug; 178(2):573-7; discussion 577. PubMed ID: 17570437
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Predictive value of resistive index, detrusor wall thickness and ultrasound estimated bladder weight regarding the outcome after transurethral prostatectomy for patients with lower urinary tract symptoms suggestive of benign prostatic obstruction.
    Huang T; Qi J; Yu YJ; Xu D; Jiao Y; Kang J; Chen YQ; Zhu YK
    Int J Urol; 2012 Apr; 19(4):343-50. PubMed ID: 22220830
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of intravesical prostatic protrusion in patients with benign prostatic enlargement.
    Keqin Z; Zhishun X; Jing Z; Haixin W; Dongqing Z; Benkang S
    Urology; 2007 Dec; 70(6):1096-9. PubMed ID: 18158025
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates to surgery.
    Iscaife A; Dos Anjos G; Barbosa C; Nahas WC; Srougi M; Antunes AA
    Int Braz J Urol; 2018; 44(4):765-770. PubMed ID: 29617085
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is intravesical prostatic protrusion associated with more complications in benign prostatic hyperplasia patients?
    Eze BU; Ani CO; Mbaeri TU
    Low Urin Tract Symptoms; 2021 Oct; 13(4):468-474. PubMed ID: 34080315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factors predicting the success of a trial without catheter in acute urinary retention secondary to benign prostatic hyperplasia.
    Bhomi KK; Bhattachan CL
    Nepal Med Coll J; 2011 Sep; 13(3):178-81. PubMed ID: 22808810
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized controlled trial on the efficacy of bladder training before removing the indwelling urinary catheter in patients with acute urinary retention associated with benign prostatic hyperplasia.
    Zhengyong Y; Changxiao H; Shibing Y; Caiwen W
    Scand J Urol; 2014 Aug; 48(4):400-4. PubMed ID: 24697345
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of intravesical prostatic protrusion, prostate volume and serum prostatic-specific antigen in the evaluation of bladder outlet obstruction.
    Lim KB; Ho H; Foo KT; Wong MY; Fook-Chong S
    Int J Urol; 2006 Dec; 13(12):1509-13. PubMed ID: 17118026
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Clinical impact of the intravesical prostatic protrusion: a review by the LUTS committee of the French Urological Association].
    Lebdai S; Ammi M; Bigot P; Cornu JN; Mathieu R; Descazeaud A; Azzouzi AR;
    Prog Urol; 2014 Apr; 24(5):313-8. PubMed ID: 24674338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decrease of ultrasound estimated bladder weight during tamsulosin treatment in patients with benign prostatic enlargement.
    Sironi D; Levorato CA; Deiana G; Borgonovo G; Belussi D; Ranieri A; Lembo A
    Arch Ital Urol Androl; 2002 Jun; 74(2):90-4. PubMed ID: 12161944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Histological changes of the prostate and acute urinary retention in patients with benign prostatic hyperplasia].
    Bao QB; He GH; Liu GY; Zhang CG; Yang C
    Zhonghua Nan Ke Xue; 2013 Sep; 19(9):811-4. PubMed ID: 24386860
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alfuzosin 10 mg once daily prevents overall clinical progression of benign prostatic hyperplasia but not acute urinary retention: results of a 2-year placebo-controlled study.
    Roehrborn CG
    BJU Int; 2006 Apr; 97(4):734-41. PubMed ID: 16536764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The relationship between intravesical prostatic protrusion and pressure flow study findings in patients with benign prostate obstruction/lower urinary tract symptoms].
    Park SC; Lee JW; Rim JS
    Actas Urol Esp; 2012 Mar; 36(3):165-70. PubMed ID: 22018947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prostate-specific antigen and transition zone index - powerful predictors for acute urinary retention in men with benign prostatic hyperplasia.
    Milonas D; Trumbeckas D
    Medicina (Kaunas); 2003; 39(11):1071-7. PubMed ID: 14646460
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the change of bladder wall weight pre and after surgery in patients with benign prostatic hyperplasia].
    Li HZ; Zhang XB; Li JC; Xiao H; Huang ZM
    Zhonghua Wai Ke Za Zhi; 2007 Jul; 45(14):954-6. PubMed ID: 17961378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ultrasound prostate parameters as predictors of successful trial without catheter after acute urinary retention in patients ongoing medical treatment for benign prostatic hyperplasia: a prospective multicenter study.
    DE Nunzio C; Voglino O; Cicione A; Tema G; Cindolo L; Bada M; Lombardo R; Nacchia A; Trucchi A; Ships L; Gacci M; Milanesi M; Cito G; Serni S; Tubaro A
    Minerva Urol Nephrol; 2021 Oct; 73(5):625-630. PubMed ID: 33200904
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dutasteride add-on therapy reduces detrusor mass in patients with benign prostatic enlargement not satisfied with alpha-adrenergic antagonist monotherapy: A single center prospective study.
    De Nunzio C; Brassetti A; Proietti F; Gacci M; Serni S; Esperto F; Tubaro A
    Neurourol Urodyn; 2017 Nov; 36(8):2096-2100. PubMed ID: 28257560
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Intravesical Prostatic Protrusion as a Predictor of Dutasteride-Resistant Lower Urinary Tract Symptoms/Benign Prostatic Enlargement With a High Likelihood of Surgical Intervention.
    Hirayama K; Masui K; Hamada A; Shichiri Y; Masuzawa N; Hamada S
    Urology; 2015 Sep; 86(3):565-9. PubMed ID: 26199172
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Correlation between intravesical prostatic protrusion and international prostate symptom score among Nigerian men with benign prostatic hyperplasia.
    Eze BU; Mbaeri TU; Oranusi KC; Abiahu JA; Nwofor AM; Orakwe JC; Mbonu OO
    Niger J Clin Pract; 2019 Apr; 22(4):454-459. PubMed ID: 30975947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of baseline variables on changes in International Prostate Symptom Score after combined therapy with dutasteride plus tamsulosin or either monotherapy in patients with benign prostatic hyperplasia and lower urinary tract symptoms: 4-year results of the CombAT study.
    Roehrborn CG; Barkin J; Tubaro A; Emberton M; Wilson TH; Brotherton BJ; Castro R
    BJU Int; 2014 Apr; 113(4):623-35. PubMed ID: 24127818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.